why choose us

First received: May 04, 2023

Clinical Trial: Molecular Signatures of Cutaneous Dupilumab Response

Study Status: Completed

Recruit Status: RECRUITING

Condition: Atopic Dermatitis

Study Type: INTERVENTIONAL


Official Title: Molecular Signatures of Cutaneous Dupilumab Response

Brief Summary: This study examines the effect of IL4RA blockade with dupilumab on the immune cells of atopic dermatitis skin lesions.

Read more